Answers are grounded in this paper and cite their sources.
Pancreatin therapy can be used safely in patients with diabetes mellitus and exocrine dysfunction. Parameters of glucose metabolism were not improved by enzyme replacement therapy.
No takes yet. Share an insight, caveat, or question.
Ewald et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: